J&J Consulting Group- FDA Regulatory Compliance
FDA MoCRA Compliance Consulting for Cosmetic Manufacturers | Expert regulatory guidance for cosmetic product safety substantiation, FDA facility registration, product listing, adverse event reporting, and label compliance under the Modernization of Cosmetics Regulation Act. Avoid penalties and ensure smooth U.S. market access.
1 (800) 999-7781
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is the most significant update to cosmetic law since 1938—expanding FDA oversight across product safety, labeling, recordkeeping, and adverse event reporting.
At [Your Company Name], we provide expert guidance and regulatory support to help your cosmetic business comply with MoCRA’s new requirements.

The FDA can order a mandatory recall if a cosmetic is adulterated or misbranded.

Cosmetic facilities must register with the FDA by July 1, 2024 for full MoCRA compliance.

Cosmetic companies must list each marketed cosmetic product, including ingredients.

Companies must provide a way for consumers to report adverse effects on packaging.
We offer comprehensive support including GMP facility setup, SOP development, process validation, audits, training, and regulatory compliance for pharmaceutical and biologic manufacturers.
Companies must develop, review, and maintain detailed safety substantiation records for all cosmetic products consistently.
Companies must follow GMP regulations and maintain proper documentation and standardized manufacturing processes.
Companies must implement reliable systems for documenting and reporting all adverse cosmetic product events.
An electronic submission portal for registering and listing cosmetic products and facilities
Xforms
Our experts handle end-to-end SPL Xforms submissions for cosmetic manufacturers, ensuring accurate FDA facility registration and product listing in full compliance with MoCRA requirements.
We streamline Form FDA 5066 and 5067 filings for cosmetic manufacturers, delivering accurate facility and products registrations that keep your operations MoCRA-compliant and audit-ready.
Expert safety substantiation services for cosmetic products — we compile and maintain MoCRA-compliant records, including ingredient assessments, toxicological reviews, and exposure data, to demonstrate product safety and protect your brand from regulatory risk.
From Formula to Shelf — MoCRA Compliance Made Simple
Navigating FDA’s Modernization of Cosmetics Regulation Act (MoCRA) can be overwhelming — from cosmetic facility registration and product listing to safety substantiation, label compliance, and adverse event reporting. Each requirement carries real risk: missed deadlines, border holds, recalls, or even suspended registrations.
We simplify the entire MoCRA compliance process for cosmetic manufacturers and responsible persons. Our regulatory team manages Form FDA 5066 and 5067 submissions, SPL Xforms filings, safety documentation, and ongoing FDA reporting — giving your brand a clear, compliant path from formula to shelf.
Professional, knowledgeable team guided us through FDA registration and complete product listing accurately and efficiently.
MoCRA (the Modernization of Cosmetics Regulation Act of 2022) is the most significant expansion of FDA’s authority over cosmetics since 1938. It introduces mandatory requirements for facility registration, product listing, safety substantiation, adverse event reporting, and label compliance. Non-compliance can result in border holds, recalls, suspended registrations, or products being deemed misbranded or adulterated.
Any manufacturer, packer, or distributor whose name appears on a cosmetic product label sold in the U.S. — known as the “Responsible Person” — must comply. This includes domestic and foreign cosmetic facilities, contract manufacturers, and brand owners. Certain small businesses are exempt, but exemptions do not apply to products involving the eye mucus membrane, injectables, internal-use products, or long-wear products.
JJCC Group provides end-to-end MoCRA compliance support, including:
Form FDA 5066 is used for cosmetic facility registration — every manufacturer or processor must register their facility and renew every two years. Form FDA 5067 is used for cosmetic product listing — the Responsible Person must list each marketed product, including its full ingredient list, and update the listing annually.
SPL Xforms is an FDA-provided tool for creating Structured Product Labeling (SPL) files used in cosmetic registration and product listing submissions. It’s ideal for manufacturers handling bulk submissions or building SPL files offline. JJCC Group manages SPL Xforms submissions on your behalf, ensuring accurate formatting and successful FDA acceptance.
Under MoCRA, every cosmetic product must have adequate substantiation of safety before being marketed. This means maintaining records — including ingredient assessments, toxicological data, and exposure evaluations — that demonstrate the product is safe under intended use. JJCC Group helps build and maintain audit-ready safety substantiation files that meet FDA's standard.
Yes. Any foreign facility registering with the FDA under MoCRA must designate a U.S. Agent who serves as the official point of contact with the FDA. JJCC Group offers U.S. Agent services, ensuring your business stays connected and responsive to FDA communications.